Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Clemastine fumarate
Cat. No.:
OB0225LY-0181
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Clemastine fumarate is a second-generation antihistamine, which is mainly used for the relief of allergic symptoms and has a strong H1 receptor antagonist effect.
Synonym:
HS-592 (fumarate); Meclastine fumarate; Meclastine (fumarate); 14976-57-9; (R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine fumarate; Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-, fumarate (1:1); (2R)-2-(2-((1R)-1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium (2E)-3-carboxyprop-2-enoate
CAS No.:
14976-57-9
Compound CID:
5281069
Formula:
C25H30ClNO5
Formula Weight:
459.97
Specification
Relative Density:
1.0247 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Clemastine fumarate can be used in the study of the mechanisms of allergic reactions or play an important role in the assessment of the effects of antihistamines.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor
Pathways:
GPCR/G protein; Immunology/Inflammation; Autophagy; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
c4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
9 mg/mL; 19.57 mM
